FDA product code SDA: Electrical Tumor Treatment Fields For Non-Small Cell Lung Cancer

SDA is the FDA product code for electrical tumor treatment fields for non-small cell lung cancer. It is a Class III device, reviewed by the Anesthesiology panel. Devices under SDA reach the market by PMA; FDA lists no cleared 510(k)s for it. 1 PMA application cites this product code.

Definition

Optune Lua concurrent with PD-1/PD-L1 inhibitors or docetaxel is indicated for adult patients with metastatic non-small cell lung cancer who have progressed on or after a platinum-based regimen.

Classification

FieldValue
Device nameElectrical Tumor Treatment Fields For Non-Small Cell Lung Cancer
Device classClass III
Review panelAN — Anesthesiology
Medical specialtyUnknown
Premarket routePMA
Life-sustaining or supportingYes

Recalls for SDA devices

FDA recall records list no recalls for product code SDA.

Frequently asked questions

What is FDA product code SDA?

SDA is the FDA product code for electrical tumor treatment fields for non-small cell lung cancer. It is a Class III device, reviewed by the Anesthesiology panel.

What device class is SDA?

Class III. Typical premarket route: PMA.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Anesthesiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times